Navigating the complex regulatory landscape is the defining characteristic of the Generic Injectable Market. As regulators tighten standards for sterility, purity, and bioequivalence, firms that prioritize quality control are gaining significant competitive advantages. The cost of compliance, while high, acts as a barrier to entry that prevents substandard products from flooding the market,...